Temozolomide resistance in human glioblastoma cell line U251 is caused by mismatch repair deficiency and can be overcome by lomustine

Stritzelberger J, Distel T, Fietkau R, Putz F (2016)

Publication Type: Conference contribution

Publication year: 2016

Journal

Oncology Research and Treatment Karger Publishers

Book Volume: 39

Pages Range: 60-60

Authors with CRIS profile

Jenny Stritzelberger Department of Radiation Oncology Rainer Fietkau Lehrstuhl für Strahlentherapie Florian Putz Department of Radiation Oncology

How to cite

APA:

Stritzelberger, J., Distel, T., Fietkau, R., & Putz, F. (2016). Temozolomide resistance in human glioblastoma cell line U251 is caused by mismatch repair deficiency and can be overcome by lomustine. (pp. 60-60).

MLA:

Stritzelberger, Jenny, et al. "Temozolomide resistance in human glioblastoma cell line U251 is caused by mismatch repair deficiency and can be overcome by lomustine." 2016. 60-60.

BibTeX: Download